SCHEMBL1667141

SCHEMBL1667141

CC(=O)c1cc2cc3cc4cc5ccccc5cc4cc3cc2cc1C(C)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.53
MAOB P27338 3/20 0.53
CA12 O43570 1/20 0.53
CYP1A2 P05177 1/20 0.53
NT5E P21589 1/20 0.53
CA9 Q16790 1/20 0.53
ALDH1A1 P00352 3/20 0.47
HPGD P15428 2/20 0.47
IDO1 P14902 1/20 0.47
MAOA P21397 1/20 0.46
IRAK4 Q9NWZ3 1/20 0.46
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
MAPT P10636 4/20 0.44
POLB P06746 2/20 0.44
GAA P10253 2/20 0.44
NSD2 O96028 1/20 0.44
MCL1 Q07820 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28466533 0.95 KDM4E (0.57) KDM4EMAOBCA12CYP1A2NT5E
SCHEMBL28561531 0.87 SMN1; SMN2 (0.52) KDM4EMAOBCA12CYP1A2NT5E
SCHEMBL11268428 0.86 IDO1 (0.59) KDM4EMAOBCA12CYP1A2NT5E
SCHEMBL14013046 0.84 SMN1; SMN2 (0.55) KDM4EMAOBCA12CYP1A2NT5E
SCHEMBL26443970 0.82 KDM4E (0.44) KDM4EMAOBCA12CYP1A2NT5E
Benz(B)Anthracene SCHEMBL31229359 0.82 ALDH1A1 (0.50) KDM4ECYP1A2ALDH1A1HPGDIDO1
SCHEMBL30137706 0.82 MEN1 (0.58) KDM4EMAOBCA12CYP1A2NT5E
SCHEMBL14781353 0.82 KDM4E (0.50) KDM4EMAOBCA12CYP1A2NT5E
SCHEMBL3893085 0.82 MEN1 (0.58) KDM4EMAOBCA12CYP1A2NT5E
Anthracene SCHEMBL28851488 0.82 CES2 (0.50) KDM4EMAOBCA12CYP1A2NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1830228-B1 COMPOUND FOR RESIST AND RADIATION-SENSITIVE COMPOSITION MITSUBISHI GAS CHEMICAL CO (JP) 2015-08-05 EP disclosed
EP-2808736-A2 Compound for resist and radiation-sensitive composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2014-12-03 EP disclosed
US-8802353-B2 Compound for resist and radiation-sensitive composition specification MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2014-08-12 US disclosed
EP-2662727-A2 Compound for resist and radiation-sensitive composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-11-13 EP disclosed
US-8350096-B2 Compound for resist and radiation-sensitive composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-01-08 US disclosed
US-20130004896-A1 COMPOUND FOR RESIST AND RADIATION-SENSITIVE COMPOSITION SPECIFICATION ECHIGO MASATOSHI (JP) 2013-01-03 US disclosed
US-20110165516-A1 COMPOUND FOR RESIST AND RADIATION-SENSITIVE COMPOSITION ECHIGO MASATOSHI 2011-07-07 US disclosed
US-7919223-B2 Polyphenol compound synthesized by condensation between aromatic ketone or aldehyde and a phenol; acid-amplified, non-polymeric resist; highly sensitive to KrF excimer lasers, extreme ultraviolet rays, electron beams, X-rays; resist patterns with high resolution, high heat, etch resistance MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2011-04-05 US disclosed
US-20080113294-A1 Compound for Resist and Radiation-Sensitive Composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2008-05-15 US disclosed
EP-1830228-A1 COMPOUND FOR RESIST AND RADIATION-SENSITIVE COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2007-09-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165516-A1 COMPOUND FOR RESIST AND RADIATION-SENSITIVE COMPOSITION XRCC6, XRCC5, KISS1R KDM4E 18/4885MAOB 1769/4885CA12 2720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.